Clinical trial

Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging.

NCT03465579

Study summary

ClinicalTrials.gov

Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging.

Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIAGNOSTIC_TEST · Unmapped registry intervention pelvic MRI Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention 68Ga-PSMA PET/CT Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2018-05-23

PhaseNA

Conditions

68Ga-PSMA PET/CT Guided Prostate Biopsyunresolved

Mp-3TMRI Guided Prostate Biopsyunresolved

Prostate Cancerverified · MONDO: prostate cancer

TNM Stagingunresolved

Diagnosisunresolved

Interventions

pelvic MRIDIAGNOSTIC_TEST

68Ga-PSMA PET/CTDIAGNOSTIC_TEST

Sponsors & collaborators

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSlead sponsor

Mapped research locations

MeldolaFC, Italy1 ForlìFC, Italy1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03465579 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.